Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention (Q44075675)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Xiao-Fang Tang

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jing Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jia-Hui Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Xian-Min Meng

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Bo Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Shu-Bin Qiao

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yong-Jian Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jue Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yuan Wu

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ji-Lin Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Run-Lin Gao

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jin-Qing Yuan

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Yue-Jin Yang

13

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

14 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

69

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1103-1112

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 200

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Effect of Paraoxonase-1 Polymorphism on Clinical Outcomes in Patients Treated With Clopidogrel After an Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study).

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1446-8

21 January 2018

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paraoxonase-1 is a major determinant of clopidogrel efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of P-glycoprotein on clopidogrel absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans

1 reference

https://pubmed.ncbi.nlm.nih.gov/23150151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-012-1446-8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44075675&oldid=2206422654"